Operating Lease, Right-of-Use Asset in USD of STANDARD BIOTOOLS INC. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Standard Biotools Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • Standard Biotools Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $23.5M, a 22.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

STANDARD BIOTOOLS INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $23.5M -$6.81M -22.5% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $24.6M -$6.96M -22.1% 30 Jun 2025 10-Q 15 Aug 2025
Q1 2025 $27.4M -$5.54M -16.8% 31 Mar 2025 10-Q 06 May 2025
Q4 2024 $26.6M -$4.1M -13.4% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 $30.3M -$927K -2.97% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $31.5M -$663K -2.06% 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $33M -$8K -0.02% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $30.7M -$3.22M -9.5% 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 $31.2M -$3.54M -10.2% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $32.2M -$3.22M -9.09% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $33M -$3.42M -9.39% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $33.9M -$3.24M -8.72% 31 Dec 2022 10-K 01 Mar 2024
Q3 2022 $34.7M -$2.97M -7.88% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $35.4M -$3.31M -8.54% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $36.4M -$856K -2.3% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $37.1M -$995K -2.61% 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 $37.7M -$771K -2% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $38.7M -$310K -0.79% 30 Jun 2021 10-Q 06 Aug 2021
Q1 2021 $37.2M -$2.25M -5.71% 31 Mar 2021 10-Q 07 May 2021
Q4 2020 $38.1M +$33.3M +684% 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 $38.5M +$33.1M +619% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $39M +$32.5M +500% 30 Jun 2020 10-Q 07 Aug 2020
Q1 2020 $39.5M +$32.3M +450% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $4.86M +$4.86M 31 Dec 2019 10-K 25 Feb 2021
Q3 2019 $5.35M 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 $6.51M 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $7.18M 31 Mar 2019 10-Q 07 May 2019
Q4 2018 $0 31 Dec 2018 10-K 27 Feb 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.